{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:19:05Z","timestamp":1783531145776,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jdcr.2024.11.035","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T16:52:31Z","timestamp":1734108751000},"page":"67-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immune checkpoint inhibitor associated lichenoid dermatitis mimicking erythema multiforme major with a germline variant in human leukocyte antigen-B15"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8637-8458","authenticated-orcid":false,"given":"Sach","family":"Thakker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Benyounes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair S.","family":"Allais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2024.11.035_bib1","first-page":"14","article-title":"Chapter 4: Lichenoid Reactions","volume":"1st ed.","author":"Allo","year":"2023"},{"issue":"4","key":"10.1016\/j.jdcr.2024.11.035_bib2","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jaad.2020.04.105","article-title":"Dermatologic toxicities to immune checkpoint inhibitor therapy: a review of histopathologic features","volume":"83","author":"Ellis","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2024.11.035_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cup.12858","article-title":"Diverse types of dermatologic toxicities from immune checkpoint blockade therapy","volume":"44","author":"Curry","year":"2017","journal-title":"J Cutan Pathol"},{"issue":"11","key":"10.1016\/j.jdcr.2024.11.035_bib4","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.jid.2022.04.020","article-title":"Cutaneous toxicities associated with immune checkpoint inhibitors: an observational, pharmacovigilance study","volume":"142","author":"Le","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdcr.2024.11.035_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3186328","article-title":"HLA association with drug-induced adverse reactions","volume":"2017","author":"Fan","year":"2017","journal-title":"J Immunol Res"},{"issue":"10","key":"10.1016\/j.jdcr.2024.11.035_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.16572","article-title":"Successful rechallenge with pembrolizumab after case of progressive immunotherapy-related mucocutaneous eruption (PIRME), a Stevens-Johnson syndrome-like reaction","volume":"62","author":"Shi","year":"2023","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jdcr.2024.11.035_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/OTT.S57335","article-title":"Ipilimumab in the treatment of metastatic melanoma: management of adverse events","volume":"7","author":"della Vittoria Scarpati","year":"2014","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.jdcr.2024.11.035_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jdin.2023.11.013","article-title":"Checkpoint inhibitor\u2013induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level","volume":"15","author":"Meier-Schiesser","year":"2024","journal-title":"JAAD Int"},{"key":"10.1016\/j.jdcr.2024.11.035_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamadermatol.2024.0210","article-title":"Human leukocyte antigens and sulfamethoxazole\/cotrimoxazole-induced severe cutaneous adverse reactions: a systematic review and meta-analysis","volume":"160","author":"Wu","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jdcr.2024.11.035_bib10","article-title":"Clinical utility of genomic testing in cancer care","volume":"6","author":"Pritchard","year":"2022","journal-title":"JCO Precis Oncol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624004867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624004867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T14:29:38Z","timestamp":1739543378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512624004867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":10,"alternative-id":["S2352512624004867"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.11.035","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune checkpoint inhibitor associated lichenoid dermatitis mimicking erythema multiforme major with a germline variant in human leukocyte antigen-B15","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}